1. The process of understanding the rapid global decline of sawfishes (Pristidae) has revealed great concern for their relatives, the wedgefishes (Rhinidae) and giant guitarfishes (Glaucostegidae), not least because all three families are targeted for their high-value and internationally-traded 'white' fins.2. The objective of this study was to assess the extinction risk of all 10 wedgefishes and 6 giant guitarfishes by applying the International Union for Conservation of Nature (IUCN) Red List Categories and Criteria, and to summarise their biogeography and habitat, life history, exploitation, use and trade, and population status.3. Wedgefishes and giant guitarfishes have overtaken sawfishes as the most imperilled marine fish families globally, with all but one of the 16 species facing an extremely high risk of extinction due to a combination of traits -limited biological productivity, presence in shallow waters overlapping with some of the most intense and increasing coastal fisheries in the world, and over-exploitation in target and bycatch fisheries driven by the need for animal protein and food security in coastal communities and trade in meat and high-value fins. 4. Two species with very restricted ranges, the Clown Wedgefish (Rhynchobatus cooki) of the Indo-Malay Archipelago and the False Shark Ray (Rhynchorhina mauritaniensis) of Mauritania may be very close to extinction. Only the Eyebrow Wedgefish (Rhynchobatus palpebratus) is not assessed as CriticallyEndangered, due to it occurring primarily in Australia where fishing pressure is low, and some management measures are in place. Australia represents a 'lifeboat' for the three wedgefish and one giant guitarfish species occurring there. 6. To conserve populations and permit recovery, a suite of measures will be required which will need to include species protection, spatial management, bycatch mitigation, and harvest and international trade management, all of which will be dependent on effective enforcement.
The biology of elasmobranchs makes them very vulnerable to fishing pressure and there is increasing international concern over their exploitation. In northern Australia the stocks of some species may be shared with those in southern Indonesia. Indonesia has the highest landings of elasmobranchs worldwide ([100,000 t p.a.) and millions of Indonesian artisanal fishers rely heavily on elasmobranchs taken in target fisheries. They are also taken by industrial trawlers and as bycatch in pelagic tuna fisheries. This paper, resulting from a collaborative project between Australia and Indonesia, summarises the elasmobranch fisheries; the characteristics of the fisheries are outlined, the status of the stocks are assessed, and management options described and discussed. The project focussed on representative markets and fish landing sites in southern Indonesia from 2001 to 2005. Data were from market surveys, the records of the Indonesian Directorate General of Capture Fisheries, and from research cruises. Data from the ongoing tuna monitoring programme showed that shark bycatch from the tuna fleets forms about 11% of shark landings in Indonesia. Yield per recruit and related analyses were used to integrate biological information to indicate the productivity of each species to allow for management policy options and constraints. Research cruise data show that catch rates of elasmobranchs in the Java Sea declined by at least one order of magnitude between 1976 and 1997. The results indicate strongly that many of the shark and ray species in Indonesia are overfished and that the most effective management strategy may need to involve capacity control, such as licencing, gear restrictions and catch limits, together with controls on the fin trade.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.